- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatocellular Carcinoma Patients in South Africa
Total 1900 results
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
PfizerCompletedOvarian CancerUnited States, Canada, Australia, France, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Austria, Denmark, Hungary, Singapore, Hong Kong, Belgium, Japan, Ireland, Italy, Netherlands, Czechia, Poland, Switzerland, Russian... and more
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer... and other conditionsUnited States
-
AstraZenecaCompletedCarcinoma | Neoplasm | Non-small-cell Lung | MetastasesUnited States
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced Colorectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States, Australia, Belgium, Brazil, Canada, Czech Republic, Greece, Korea, Republic of, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain
-
National Cancer Institute (NCI)NRG OncologyTerminatedStage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
Bristol-Myers SquibbWithdrawnStomach Cancer | Gastric Cancer | Cancer of the Stomach | Gastroesophageal JunctionBrazil, Italy, United States, Argentina, Chile, Germany, Spain, Australia, Canada, Portugal, Mexico, Romania, Colombia, Puerto Rico
-
Regeneron PharmaceuticalsSanofiCompletedSquamous Cell Carcinoma (SCC) | Recurrent or Metastatic, Platinum-refractory Cervical CancerSpain, Korea, Republic of, United States, United Kingdom, Taiwan, Brazil, Belgium, Australia, Italy, Canada, Japan, Greece, Poland, Russian Federation
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Revolution Medicines, Inc.Active, not recruitingAdvanced Solid Tumor | Pancreatic Ductal Adenocarcinoma | Non-Small Cell Lung Cancer (NSCLC) | Colorectal Cancer (CRC)United States, Spain, France, Korea, Republic of, Malaysia, Taiwan, Italy, Thailand, Australia, Czechia, Singapore, Poland, Serbia
-
ImmunoGen, Inc.Active, not recruitingFallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Ovarian CancerUnited States, United Kingdom, Belgium, Spain, Canada, Georgia
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials Group; Division of Cancer... and other collaboratorsActive, not recruitingBreast CarcinomaUnited States, Canada, Puerto Rico, Guam
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)SuspendedInvasive Breast Carcinoma | HER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
NantCell, Inc.CompletedPancreatic Cancer | Adenocarcinoma of the Pancreas | Metastatic Pancreatic CancerUnited States
-
NovoCure Ltd.CompletedOvarian CancerUnited States, Israel, Belgium, Netherlands, Hungary, Germany, Poland, Canada, Austria, Czechia, Italy, Spain, Switzerland
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Neuroendocrine Neoplasm | Myeloproliferative Neoplasm | Desmoid Fibromatosis | Lymphoproliferative Disorder | Carcinoma In Situ | Central Nervous System Neoplasm | Ganglioneuroma | Congenital Mesoblastic Nephroma | Childhood Immature Teratoma | Childhood Langerhans Cell Histiocytosis and other conditionsUnited States, Puerto Rico, Canada, Australia, New Zealand, Saudi Arabia
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Uterine Corpus Cancer | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Endometrioid AdenocarcinomaUnited States
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
Gilead SciencesCompletedPancreatic CancerUnited States, Russian Federation
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Clear Cell Cystadenocarcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States, Korea, Republic of, Japan
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Belgium, Spain, Israel, Australia, Ireland, Germany, Italy, Bulgaria, Czechia, Poland
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
National Cancer Institute (NCI)NRG OncologyRecruitingEndometrial Serous Adenocarcinoma | Uterine Corpus CarcinosarcomaUnited States, Puerto Rico
-
CanariaBio Inc.Gynecologic Oncology Group; Iqvia Pty LtdActive, not recruitingOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Peritoneal Carcinoma | Peritoneal Cancer | Fallopian Tube Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Ovarian Serous AdenocarcinomaKorea, Republic of, United States, Taiwan, Czechia, Argentina, Spain, Belgium, Brazil, Chile, Canada, Italy, Hungary, India, Mexico
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingGlioma | Cholangiocarcinoma | Chondrosarcoma | Any Solid TumorUnited States, Spain, Korea, Republic of, Australia, Japan, Taiwan, France, Singapore, Hong Kong
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerIsrael, United States, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian CancerUnited States, Germany, Israel, Canada, China, Australia, Belgium, Brazil, Chile, Colombia, Denmark, Finland, France, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Poland, Russian Federation, Turkey and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingColorectal AdenocarcinomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyCompletedFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 3 Endometrial Endometrioid AdenocarcinomaUnited States
-
Panbela Therapeutics, Inc.RecruitingPancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IVUnited States, Belgium, Germany, Spain, Korea, Republic of, Australia, France, Italy, Austria, United Kingdom
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer AJCC v6 and v7United States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
NGM Biopharmaceuticals, IncActive, not recruitingMelanoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostate Cancer | Head Neck Squamous Cell CarcinomaUnited States
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Endometrioid Adenocarcinoma | Stage I Uterine Corpus Cancer AJCC v8 | Stage II Uterine Corpus Cancer AJCC v8United States, Puerto Rico